Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Clinical evaluation of extra-h...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool

Bibliographic Details
Main Authors: Matteo G. Della Porta, Ilaria Ambaglio, Marta Ubezio, Erica Travaglino, Cristiana Pascutto, Luca Malcovati
Format: Article
Language:English
Published: Ferrata Storti Foundation 2012-04-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/6281
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/6281

Similar Items

  • Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
    by: Matteo G. Della Porta, et al.
    Published: (2011-03-01)
  • Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome
    by: Matteo Giovanni Della Porta, et al.
    Published: (2009-05-01)
  • Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
    by: Luca Malcovati, et al.
    Published: (2011-10-01)
  • Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
    by: Ilaria Ambaglio, et al.
    Published: (2013-03-01)
  • Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    by: Malcovati, L, et al.
    Published: (2011)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs